Make your money go further for just 25p per day

AIM IHT

Eyewear specialist looks well-placed to thrive

18/06/2021 · Inspecs (SPEC) 

AIM Inheritance Tax potential UK

Inspecs

The eyewear specialist covered here had an eventful 2020. Having weathered a very tricky period over lockdown, and with two acquisitions already under its belt, the growth opportunity looks substantial. It looks another interesting AIM company to follow, and seemingly far more modestly valued than its giant sector peer. Read on to find out more in our free introduction here


The latest results from INSPECS (LON:SPEC), the Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses, cover an eventful year which featured a little bit of everything. 

Our earlier premium commentary here ‘Inspecs - looking good value’ highlighted the appeal of the shares when they were only 185 pence. They have performed strongly since, currently standing at 351 pence (up 90%), with the market capitalisation £355m. Despite the strong move, there appears to be plenty more…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Inspecs

An unusual AIM company with a whopping dividend

10/06/2024 · Company Insights

An AIM company covered here has a lot to say but is certainly flying under the…


Episode 21 of the Investor’s Champion Podcast

08/06/2024 · Podcasts

In this episode of the Investors Champion podcast, hosts Chris and Lee discuss the challenges faced…


More Company Insights

Bonkers Bargains: another great update

18/07/2024 · Alumasc Group PLC

Chain cheers | Interest winner | Meaty first

17/07/2024 · Agronomics · Gateley · Renold · Team17

Big growth in human challenge trials

17/07/2024

Sign-up to our free email updates

SIGN UP